Rehan Verjee
CIK: 0001880637
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TYRA
Tyra Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 9, 2026TYRA
Tyra Biosciences, Inc.
Purchase(P)Direct972 shares at avg. $20.58$20K - May 28, 2026TYRA
Tyra Biosciences, Inc.
Award(A)DirectStock Option (Right to Buy)
13.2K shares- - May 29, 2025TYRA
Tyra Biosciences, Inc.
Award(A)DirectStock Option (Right to Buy)
22.2K shares-
1-3 of 3 transactions
About Verjee Rehan
Verjee Rehan (SEC CIK 0001880637) files insider reports with the SEC as Director of Tyra Biosciences, Inc. (TYRA).
Signal8 holds 3 ownership filings by Verjee Rehan, all Form 4s, filed between Jun 2, 2025 and Sep 11, 2026. Those filings report 3 transactions, from May 29, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Verjee Rehan's filings is in CARLSBAD, CA.
Recent filings by Verjee Rehan
Other insiders filing for Tyra Biosciences, Inc. (TYRA)
- Harris Todd, President and CEO
- Rueb Yuliya, Vice President, Finance (PAO)
- Fuhrman Alan, Chief Financial Officer
- RA CAPITAL MANAGEMENT, L.P., Director
- Moran Susan, Director
- Simson Jake, Director